Drug Trial Radar · NCT01306331
Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel
Last checked: Nov 19, 2026Latest source record: Jul 12, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,389
Actual
Start
Apr 2011
Primary completion
Jun 2014
Study completion Jun 2014
Sponsor
- Lead sponsor
- Evofem Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Premier Research
- First posted
- Mar 1, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- Female only, from 18 years, up to 35 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a research study of a new experimental vaginal gel that helps in vaginal pH regulation and results in immobilization of spermatozoa by maintaining the normally low vaginal pH, even in the presence of semen. This vaginal gel is called Phexxi™ (previously known as Amphora) and was compared to a commercially available spermicide called Conceptrol®, which contains nonoxynol 9; commonly abbreviated as N-9. Conceptrol® can help prevent pregnancy. This study objective was to determine if this product prevents pregnancy when inserted into the vagina before intercourse.
Conditions
- Contraception
Interventions
ConceptrolDrug
• Conceptrol® Vaginal Gel, which contains 100 mg (4% concentration) of nonoxynol-9 (N-9) in 2.5 mL volume of gel.
AmphoraDrug
• Amphora™ gel, which will be delivered in 5 mL doses, is a clear, water-based, petroleum-free gel.
Primary outcomes
What the sponsor says the trial is designed to measure.
- 6-Month (183 Days) Cumulative Pregnancy PercentageTime frame: 183 days
Locations
52 sites in 2 countries. Site status is shown where the registry gives one.
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama
Lynn Institute of the Ozarks
Little Rock, Arkansas
Advanced Clinical Research Institute
Anaheim, California
Anaheim Clinical Trials, LLC
Anaheim, California
California Family Health Council, Inc.
Berkeley, California
California Family and Health Council, Inc., LA
Los Angeles, California
California Family Health Council
Los Angeles, California
Women's Health Care
San Diego, California
Downtown Women's Healthcare
Denver, Colorado
Planned Parenthood of the Rocky Mountains
Denver, Colorado
Stamford Therapeutics Consortium
Stamford, Connecticut
Meridien Research
Bradenton, Florida
Avail Clinical Reseach
DeLand, Florida
Altus Research
Lake Worth, Florida
Miami Research Associates
Miami, Florida
Segal Institute for Clinical Research
North Miami, Florida
Meridien Research
St. Petersburg, Florida
Comprehensive Clinical Trials
West Palm Beach, Florida
Soapstone Center for Clinical Research
Decatur, Georgia
Rosemark WomenCare Specialist
Idaho Falls, Idaho
Heartland Research Associates, LLC
Wichita, Kansas
Johns Hopkins Community Physicians
Baltimore, Maryland
Impact Clinical Trials
Las Vegas, Nevada
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
NYU Medical Center Family Planning
New York, New York
Columbia University Medical Center, Division of Family Planning
New York, New York
Eastern Carolina Women's Center
New Bern, North Carolina
Wake Research Associates
Raleigh, North Carolina
University of Cincinnati
Cincinnati, Ohio
Planned Parenthood of Northeast Ohio
Cleveland, Ohio
Oregon Health Sciences University
Portland, Oregon
University of Pennsylvania Medical Center, Reproductive Research Unit
Philadelphia, Pennsylvania
Philadelphia Clinical Research
Philadelphia, Pennsylvania
Magee-Womens Hospital
Pittsburgh, Pennsylvania
Advanced Research Associates
Corpus Christi, Texas
Practice Research Organization
Dallas, Texas
UT Southwestern Medical Center - Dept. of OB/GYN
Dallas, Texas
TMC Life Research, Inc
Houston, Texas
MacArthur OB/GYN
Irving, Texas
Jean Brown Research
Salt Lake City, Utah
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.